The 5-HT(1A) antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain

Neuroscience Letters

Volumn 219, Issue 2, 1996, Pages 123-126

  Romero, Luz ^a   Hervás, Ildefonso ^a   Artigas, Francesc ^a  

^a INST D INVESTIGACIONS B   (Spain)

Author keywords

5 Hydroxytryptamine uptake inhibitors; 5 Hydroxytryptamine(1A) receptor antagonists; Citalopram; Clomipramine; Desipramine; Fluoxetine; Phenelzine

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; CLOMIPRAMINE; DESIPRAMINE; FLUOXETINE; FLUVOXAMINE; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PHENELZINE; PRESYNAPTIC RECEPTOR; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SEROTONIN ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; PIPERAZINE DERIVATIVE; PYRIDINE DERIVATIVE; SEROTONIN;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; MALE; MICRODIALYSIS; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN RELEASE; SEROTONINERGIC SYSTEM; ANIMAL; BRAIN; DOSE RESPONSE; DRUG EFFECT; DRUG POTENTIATION; METABOLISM; SYNAPTOSOME; WISTAR RAT;

ANIMALS; ANTIDEPRESSIVE AGENTS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; MALE; MICRODIALYSIS; PIPERAZINES; PRESYNAPTIC TERMINALS; PYRIDINES; RATS; RATS, WISTAR; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0030598202     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(96)13199-2     Document Type: Article

References (25)

1. [1] Adell, A. and Artigas, F., Differential effects of clomipramine given locally or systemically on extracellular 5-hydroxytryptamine in raphe nuclei and frontal cortex. An in vivo microdialysis study, Naunyn-Schmiedberg's Arch. Pharmacol., 343 (1991) 237-244.
2. [2] Artigas, F., 5-HT and antidepressants: new views from microdialysis studies, Trends Pharmacol. Sci., 14 (1993) 262.
3. [3] Artigas, F., Perez, V. and Alvarez, E., Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors, Arch. Gen. Psychiatry, 51 (1994) 248-251.
4. 1A antagonists. Regional selectivity and role of somatodendritic autoreceptors,. Soc. Neurosci. Abstr., 22 (1996) 527.19.
5. 1A antagonists, Trends Neurosci., 19 (1996) 378-383.
6. [6] Bel, N. and Artigas, F., Fluvoxamine preferentially increases extracellular 5-hydroxytryptamine in the raphe nuclei: an in vivo microdialysis study, Eur. J. Pharmacol., 229 (1992) 101-103.
7. [7] Blier, P. and Bergeron, R., Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression, J. Clin. Psychopharmacol., 15 (1995) 217-222.
8. [8] Blier, P. and De Montigny, C., Current advances and trends in the treatment of depression, Trends Pharmacol. Sci., 15 (1994) 220-226.
9. [9] Blier, P., Bergeron, R., de Montigny, C. and Blier, P., Present and future tools to improve the antidepressant response based on the differential properties of 5-HT receptor subtypes, Eur. Neuropsychopharmacol., 6 (1996) 17.
10. [10] Carboni, E. and Di Chiara, G., Serotonin release estimated by transcortical dialysis in freely-moving animals, Neuroscience, 32 (1989) 637-645.
11. 3H]paroxetine, Neuroscience, 27 (1988) 473-496.
12. [12] Ferrer, A. and Artigas, F., Effects of single and chronic treatment with the antidepressant tranylcypromine on serotonergic function in rat brain, Eur. J. Pharmacol., 263 (1994) 227-234.
13. 1A receptor antagonist, Behav. Brain Res., 73 (1995) 337-353.
14. 1A receptor antagonist and an SSRI in vivo: Effects on 5-HT cell firing and extracellular 5-HT, Br. J. Pharmacol., 115 (1995) 1064-1070.
15. [15] Hoyer, D. and Schoeffter, P., 5-HT receptors: subtypes and second messengers, J. Receptor Res., 11 (1991) 197-214.
16. 3H]imipramine localization and relationship to serotonin transporter, J. Pharmacol. Exp. Ther., 252 (1990) 410-418.
17. [17] Invernizzi, R., Belli, S. and Samanin, R., Citalopram's ability to increase the extracellular concentration of serotonin in the dorsal raphe prevents the drug's effect in frontal cortex, Brain Res., 584 (1992) 322-324.
18. [18] Malagié, I., Trillat, A.C., Jacquot, C. and Gardier, A., Effects of acute fluoxetine on extracellular serotonin levels in the raphe: an in vivo microdialysis study, Eur. J. Pharmacol., 286 (1996) 213-217.
19. [19] Paxinos, G. and Watson, C., The Rat Brain in Stereotaxic Coordinates, Academic Press, Sydney, 1982.
20. [20] Romero, L., Celada, P. and Artigas, F., Reduction of in vivo striatal 5-hydroxytryptamine release by 8-OH-DPAT after inactivation of Gi/Go proteins in dorsal raphe nucleus, Eur. J. Pharmacol., 265 (1994) 103-106.
21. 1A receptors: in vivo microdialysis and electrophysiological studies in the rat brain, Neuropsychopharmacology, 15 (1996) 349-360.
22. 3H-Ro 19-6327 in vitro: localization and abundance of MAO-A and MAO-B in rat CNS, peripheral organs, and human brain, J. Neurosci., 12 (1992) 1977-1999.
23. [23] Scuvée-Moreau, J. and Dresse, A., Effects of various antidepressant drugs on the spontaneous firing rate of locus coreuleus and dorsal raphe neurons of the rat, Eur. J. Pharmacol., 57 (1979) 219-225.
24. [24] Sotelo, C., Cholley, B., Mestikawy, S.E., Gozlan, H. and Hamon, M., Direct immunohistochemical evidence of the existence of 5-HT autoreceptors on serotonergic neurons in the midbrain raphe nuclei, Eur. J. Neurosci., 2 (1990) 1144-1154.
25. 1B agonists, Synapse, 1 (1987) 3-9.